Archive - Biotech Readout

>30% weight loss, new blood pressure drug, FcRn cracks rheumatoid arthritis, and more

Weekly Readout #8: Week ending May 22, 2026

8 hrs ago • Céline

Eli Lilly to Acquire Engage Bio

A founder-led startup aiming to solve gene therapy's "last mile" problem

May 20 • Céline

Beyond autologous CAR-T: allogeneic, in vivo, and T-cell engagers (TCE)

May 16

Weight loss maintenance strategies, 70-year hunt for metformin's mechanism, and more

Weekly Readout #7: Week of May 11, 2026

May 15 • Céline

Eli Lilly to Acquire Kelonia

Digging into the in vivo CAR-T gold rush

May 11 • Céline

Immunology Civil War, the discovery of T-cells, and their rebirth as medicines

May 9 • Céline

First approved PROTAC, obesity drug for alcoholism, and more

Weekly Readout #6: Week of May 4, 2026

May 8 • Céline

Bayer to Acquire Perfuse

A long-acting diabetic eye disease play

May 6

UCB to Acquire Candid

Scooping a reverse merger for a TCE pipeline

May 4 • Céline

Obesity, Part 2

Evolution of treatments: from dark age to golden age

May 1 • Céline

First successful Phase 3 for an in vivo CRISPR gene therapy, and more

Weekly Readout #5: Week of April 27, 2026

May 1 • Céline

April 2026

First approval for genetic hearing loss, AACR and AAN data and more

Weekly Readout #4: Week of April 20, 2026

Apr 30

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts